Related Experiment Video
Updated: Apr 23, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Integrin Beta 4 Protein Expression Bimodally Predicts Sensitivity to CDK4/6 Inhibition and Resistance to
Zhi-Min Zhu1, Lei Hu2, Yan-Wen Ma3
1Department of Pharmaceutics, Shanghai Eighth People's Hospital, Shanghai, China, sh8y.com.
Integrin beta 4 (ITGB4) protein levels, not RNA, predict breast cancer outcomes. High ITGB4 indicates better prognosis and CDK4/6 inhibitor sensitivity in ER-positive cases, but immunotherapy resistance in triple-negative breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Integrin beta 4 (ITGB4) role in breast cancer is debated due to inconsistent RNA vs. protein findings.
- Distinguishing ITGB4 RNA and protein levels is crucial for its clinical utility.
Purpose of the Study:
- To investigate the clinical significance of ITGB4 protein expression across breast cancer subtypes.
- To explore ITGB4's role in predicting response to targeted therapies and immunotherapy.
Main Methods:
- Integrated multiomics analysis of ITGB4 using TCGA, CPTAC, METABRIC, and GEO data.
- Functional validation via CDK4/6 inhibition and immunohistochemistry on triple-negative breast cancer (TNBC) tissue microarrays.
Main Results:
- Significant RNA-protein discordance for ITGB4 observed across breast cancer subtypes.
- High ITGB4 protein predicts favorable prognosis and CDK4/6 inhibitor sensitivity in ER-positive breast cancer.
- High ITGB4 in TNBC correlates with immunotherapy resistance, increased PD-L1/PD-L2, and reduced cytotoxic T-cell infiltration.
Conclusions:
- ITGB4 protein expression is a bimodal biomarker in breast cancer.
- ITGB4 predicts CDK4/6 inhibitor sensitivity in luminal subtypes and immunotherapy resistance in TNBC.
- ITGB4 protein is a critical biomarker for guiding personalized precision oncology treatments.
More Related Videos
08:08Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...